What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Immune system
The scientist’s investigation covers issues in Epitope, Antigen, Immunology, Peptide and Major histocompatibility complex.
His Epitope research incorporates themes from T lymphocyte, Virology, CD8, Human leukocyte antigen and Cytotoxic T cell.
Stefan Stevanovic interconnects Cancer research, T cell, Immune system, Immunotherapy and Vaccination in the investigation of issues within Antigen.
His Immunology research includes elements of Ex vivo, Internal medicine and Oncology.
His research integrates issues of Amino acid, Genetics and Gene in his study of Peptide.
His Major histocompatibility complex research is multidisciplinary, relying on both Plasma protein binding, Computational biology and Antigen presentation.
His most cited work include:
- SYFPEITHI: database for MHC ligands and peptide motifs. (2108 citations)
- MHC ligands and peptide motifs: first listing. (1684 citations)
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival (651 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Antigen, Epitope, Human leukocyte antigen and T cell are his primary areas of study.
His biological study spans a wide range of topics, including Cytotoxic T cell and Transplantation.
His work carried out in the field of Antigen brings together such families of science as Cancer research and Immune system, Tumor antigen, Immunotherapy.
His research in Epitope intersects with topics in Virology, MHC class I, CD8, Major histocompatibility complex and Molecular biology.
His study looks at the intersection of Major histocompatibility complex and topics like Peptide with Amino acid, Peptide sequence, Genetics and Peptide binding.
His Human leukocyte antigen research integrates issues from Leukemia and Myeloid leukemia.
He most often published in these fields:
- Immunology (36.32%)
- Antigen (37.39%)
- Epitope (32.26%)
What were the highlights of his more recent work (between 2017-2021)?
- Human leukocyte antigen (33.33%)
- Antigen (37.39%)
- T cell (28.21%)
In recent papers he was focusing on the following fields of study:
His main research concerns Human leukocyte antigen, Antigen, T cell, Cancer research and Immunotherapy.
Stefan Stevanovic has researched Antigen in several fields, including Cytotoxic T cell, Chronic lymphocytic leukemia, Peptide and Cancer immunotherapy.
His T cell study incorporates themes from Epitope, Peripheral blood mononuclear cell, CD8 and Virology.
His Epitope research is under the purview of Immunology.
His Cancer research study integrates concerns from other disciplines, such as Cancer, Immune system and Antigen presentation.
His Antigen presentation research incorporates themes from MHC class I, Major histocompatibility complex and Oncolytic virus.
Between 2017 and 2021, his most popular works were:
- Actively personalized vaccination trial for newly diagnosed glioblastoma (249 citations)
- Actively personalized vaccination trial for newly diagnosed glioblastoma (249 citations)
- SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. (88 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Immune system
His primary areas of study are Human leukocyte antigen, Antigen, T cell, Cancer research and Immunotherapy.
He has included themes like Epitope, Melanoma, Computational biology and Immune system in his Human leukocyte antigen study.
In his study, Immunity, Subdominant, Virology and T-Cell Epitopes is inextricably linked to Heterologous, which falls within the broad field of T cell.
His studies deal with areas such as Cancer, CD8, Antigen presentation and Immunogenicity as well as Cancer research.
Stefan Stevanovic combines subjects such as Tumor Escape and MHC class I, Major histocompatibility complex with his study of Antigen presentation.
His work on Cytotoxic T cell expands to the thematically related Immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
